Neuropathy - Exponent of Accelerated Involution in Uremia: The Role of Carbamylation

Tatjana Lazarevic; Zoran Kovacevic

doi:10.2478/sjecr-2021-0013

.blurhash-client-img { display: none !important; }

Neuropathy - Exponent of Accelerated Involution in Uremia: The Role of Carbamylation

EABR. Experimental and Applied Biomedical Research

AHEAD OF PRINT

By: Tatjana Lazarevic and Zoran Kovacevic

Open Access

|Sep 2021

1. Uremic neuropathy: an overview of the current literature REVIEW ARTICLE Rev. Assoc. Med. Bras. 2019 Feb;65(2):281-286.10.1590/1806-9282.65.2.28130892456
Open DOI Search in Google Scholar Back to article
2. Chillon J.M., Massy Z.A., Stengel B. Neurological complications in chronic kidney disease patients. Nephrol. Dial. Transplant. 2016 Oct;31(10):1606-14.10.1093/ndt/gfv31526359201
Open DOI Search in Google Scholar Back to article
3. Lau WL, Huisa BN, Fisher M.The Cerebrovascular- Chronic Kidney Disease Connection: Perspectives and Mechanisms.Transl Stroke Res. 2017 Feb;8(1):67-76.10.1007/s12975-016-0499-x524133627628245
Open DOI Search in Google Scholar Back to article
4. Lakshman SG, Ravikumar P, Kar G, Das D, Bhattacharjee K, Bhattacharjee P. A Comparative Study of Neurological Complications in Chronic Kidney Disease with Special Reference to its Stages and Haemodialysis Status. J Clin Diagn Res. 2016;10(12):OC01-OC04.10.7860/JCDR/2016/22815.8947529647428208901
Open DOI Search in Google Scholar Back to article
5. Vanholder R. et al. Review Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. Toxins. 2018; 10(1), 33.
Search in Google Scholar Back to article
6. Lisowska-Myjak B. Uremic Toxins and Their Effects on Multiple Organ Systems. Nephron Clin Pract. 2014; 128:303-311.10.1159/00036981725531673
Open DOI Search in Google Scholar Back to article
7. Assem M, Lando M,Grissi M, Kamel S, Massy ZA, Chillon J, Hénaut L. The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders. Toxins. 2018; 10(7): 303.10.3390/toxins10070303607109230037144
Open DOI Search in Google Scholar Back to article
8. Vanholder R,Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J. A bench to bedside view of uremic toxins.J Am Soc Nephrol. 2008; 19: 863-870.10.1681/ASN.200712137718287557
Open DOI Search in Google Scholar Back to article
9. Gillery P, Jaisson S. Usefulness of non-enzymatic posttranslational modification derived products (PTMDPs) as biomarkers of chronic diseases, J. Proteomics. 2013; 228-238. 2013 Oct 30;92:228-38.
Search in Google Scholar Back to article
10. Jaisson S, Gillery P. Evaluation of nonenzymatic posttranslational modificationderived products as biomarkers of molecular aging of proteins, Clin. Chem.56, 2010; 1401-1412. 2010 Sep;56(9):1401-12.
Search in Google Scholar Back to article
11. S. Jaisson, A. Desmons, L. Gorisse, P. Gillery, Protein molecular aging: which role in physiopathology? Med. Sci. 2017 Feb;33(2):176-182.10.1051/medsci/2017330201328240209
Open DOI Search in Google Scholar Back to article
12. P. Gillery, S. Jaisson, Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin. Chem. Lab. Med. 2014 Jan 1;52(1):33-8.10.1515/cclm-2012-088023454717
Open DOI Search in Google Scholar Back to article
13. D.R. Sell, M.A. Lane, W.A. Johnson, E.J. Masoro, O.B. Mock, K.M. Reiser, J.F. Fogarty, R.G. Cutler, D.K. Ingram, G.S. Roth, V.M. Monnier, Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence, Proc. Natl. Acad. Sci. U. S. A. 1996 Jan 9;93(1):485-90.10.1073/pnas.93.1.485402638552666
Open DOI Search in Google Scholar Back to article
14. R. Meerwaldt, J.W. Hartog, R. Graaff, R.J. Huisman, T.P. Links, N.C. den Hollander, S.R. Thorpe, J.W. Baynes, G. Navis, R.O. Gans, A.J. Smit, Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients, J. Am. Soc. Nephrol. 2005 Dec;16(12):3687-93.10.1681/ASN.200502014416280473
Open DOI Search in Google Scholar Back to article
15. R.P. van Waateringe, S.N. Slagter, A.P. van Beek, M.M. van der Klauw, J.V. van Vliet-Ostaptchouk, R. Graaff, A.D. Paterson, H.L. Lutgers, B.H.R. Wolffenbuttel, Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components, Diabetol. Metab. Syndr. 2017 May 30;9:42.10.1186/s13098-017-0241-1545015428572855
Open DOI Search in Google Scholar Back to article
16. Jaisson, S., Pietrement, C., & Gillery, P. Protein Carbamylation: Chemistry, Pathophysiological Involvement, and Biomarkers. Advances in Clinical Chemistry.. 2018;84:1-38.
Search in Google Scholar Back to article
17. Jaisson, I. Kazes, A. Desmons, F. Fadel, J.B. Oudart, I.C. Santos-Weiss, H. Millart, F. Toure, P. Rieu, P. Gillery, Homocitrulline as marker of protein carbamylation in hemodialyzed patients, Clin. Chim. Acta. 2016 Sep 1;460:5-10.10.1016/j.cca.2016.06.00927302313
Open DOI Search in Google Scholar Back to article
18. L. Gorisse, C. Pietrement, V. Vuiblet, C.E. Schmelzer, M. Kohler, L. Duca, L. Debelle, P. Fornes, S. Jaisson, P. Gillery, Protein carbamylation is a hallmark of aging, Proc. Natl. Acad. Sci..PNAS February 2, 2016; 113 (5) 1191-119610.1073/pnas.1517096113474774326712018
Open DOI Search in Google Scholar Back to article
19. Delanghe, S.; Delanghe, J.R.; Speeckaert, R.; Van Biesen, W.; Speeckaert, M.M. Mechanisms and consequences of carbamoylation. Nat. Rev. Nephrol. 2017 Sep;13(9):580-593.10.1038/nrneph.2017.10328757635
Open DOI Search in Google Scholar Back to article
20. S. Kalim, C.A. Trottier, J.B. Wenger, J. Wibecan, R. Ahmed, E. Ankers, S.A. Karumanchi, R. Thadhani, A.H. Berg, Longitudinal changes in protein carbamylation and mortality risk after initiation of hemodialysis, Clin. J. Am. Soc. Nephrol. 2016 Oct 7;11(10):1809-1816.10.2215/CJN.02390316505378927445162
Open DOI Search in Google Scholar Back to article
21. E.O. Apostolov, D. Ray, A.V. Savenka, S.V. Shah, A.G. Basnakian, Chronic uremia stimulates LDL carbamylation and atherosclerosis, J. Am. Soc. Nephrol. 2010 Nov; 21(11): 1852-1857.10.1681/ASN.2010040365301400020947625
Open DOI Search in Google Scholar Back to article
22. E.O. Apostolov, A.G. Basnakian, E. Ok, S.V. Shah, Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease, J. Ren. Nutr. 2012 Jan;22(1):134-8.10.1053/j.jrn.2011.10.02322200430
Open DOI Search in Google Scholar Back to article
23. W.H. Tang, K. Shrestha, Z. Wang, A.G. Borowski, R.W. Troughton, A.L. Klein, S.L. Hazen, Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes, J. Card. Fail. 2013 Apr;19(4):219-24.10.1016/j.cardfail.2013.02.001363550023582087
Open DOI Search in Google Scholar Back to article
24. S. Jaisson, M. Kerkeni, I.C. Santos-Weiss, F. Addad, M. Hammami, P. Gillery, Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease, Clin. Chem. Lab. Med. 2015 Jan;53(1):103-10.10.1515/cclm-2014-064225153409
Open DOI Search in Google Scholar Back to article
25. Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease, Cardiol Res Prac. 2011; 2011:306189.
Search in Google Scholar Back to article
26. Toyoda K. Cerebral small vessel disease and chronic kidney disease. J Stroke. 2015;17(1):31-7.10.5853/jos.2015.17.1.31432563325692105
Open DOI Search in Google Scholar Back to article
27. Seliger SL, Sarnak MJ. Subclinical vascular disease of the brain in dialysis patients. Am J Kidney Dis. 2007;50(1):8-10. Plus referenca broj 79 na strani 1310.1053/j.ajkd.2007.04.02217591520
Open DOI Search in Google Scholar Back to article
28. E.O. Apostolov, D. Ray, A.V. Savenka, S.V. Shah, A.G. Basnakian, Chronic uremia stimulates LDL carbamylation and atherosclerosis, J. Am. Soc. Nephrol. 2010 Nov;21(11):1852-7.10.1681/ASN.2010040365301400020947625
Open DOI Search in Google Scholar Back to article
29. E.O. Apostolov, A.G. Basnakian, E. Ok, S.V. Shah, Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease, J. Ren. Nutr. 2012 Jan;22(1):134-8.10.1053/j.jrn.2011.10.02322200430
Open DOI Search in Google Scholar Back to article
30. M. Holzer, M. Gauster, T. Pfeifer, C. Wadsack, G. Fauler, P. Stiegler, H. Koefeler, E. Beubler, R. Schuligoi, A. Heinemann, G. Marsche, Protein carbamylation renders high-density lipoprotein dysfunctional, Antioxid. Redox Signal.2011 Jun 15;14(12):2337-4610.1089/ars.2010.3640338053121235354
Open DOI Search in Google Scholar Back to article
31. Speer, F.O. Owala, E.W. Holy, S. Zewinger, F.L. Frenzel, B.E. Stahli, M. Razavi, S. Triem, H. Cvija, L. Rohrer, S. Seiler, G.H. Heine, V. Jankowski, J. Jankowski, G.G. Camici, A. Akhmedov, D. Fliser, T.F. Luscher, F.C. Tanner, Carbamylated low-density lipoprotein induces endothelial dysfunction, Eur. Heart J. 2014 Nov 14;35(43):3021-32.10.1093/eurheartj/ehu11124658767
Open DOI Search in Google Scholar Back to article
32. J. Carracedo, A. Merino, C. Briceno, S. Soriano, P. Buendia, L. Calleros, M. Rodriguez, A. Martin-Malo, P. Aljama, R. Ramirez, Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells, FASEB J. 2011 Apr;25(4):1314-22.10.1096/fj.10-17337721228221
Open DOI Search in Google Scholar Back to article
33. Pieniazek, K. Gwozdzinski, Carbamylation and oxidation of proteins lead to apoptotic death of lymphocytes, Chem. Biol. Interact. 2017 May 25;270:24-32.10.1016/j.cbi.2017.04.00728400100
Open DOI Search in Google Scholar Back to article
34. Koro, A. Hellvard, N. Delaleu, V. Binder, C. Scavenius, B. Bergum, I. Glowczyk, H.M. Roberts, I.L. Chapple, M.M. Grant, M. Rapala-Kozik, K. Klaga, J.J. Enghild, J. Potempa, P. Mydel, Carbamylated Il-37 as a modulator of the immune response, Innate Immun. 2016 Apr; 22(3): 218-229.10.1177/1753425916631404514367326878866
Open DOI Search in Google Scholar Back to article
35. Koro, E. Bielecka, A. Dahl-Knudsen, J.J. Enghild, C. Scavenius, J.G. Brun, V. Binder, A. Hellvard, B. Bergum, R. Jonsson, J. Potempa, A.M. Blom, P. Mydel, Carbamylation of immunoglobulin abrogates activation of the classical complement pathway, Eur. J. Immunol. 2014 Nov;44(11):3403-12.10.1002/eji.201444869423299225130613
Open DOI Search in Google Scholar Back to article
36. E.W. Holy, A. Akhmedov, T. Speer, G.G. Camici, S. Zewinger, N. Bonetti, J.H. Beer, T.F. Luscher, F.C. Tanner, Carbamylated low-density lipoproteins induce a prothrombotic state via LOX-1: impact on arterial thrombus formation in vivo, J. Am. Coll. Cardiol. 2016 Oct 11;68(15):1664-1676.10.1016/j.jacc.2016.07.75527712780
Open DOI Search in Google Scholar Back to article
37. V. Binder, B. Bergum, S. Jaisson, P. Gillery, C. Scavenius, E. Spriet, A.K. Nyhaug, H.M. Roberts, I.L.C. Chapple, A. Hellvard, N. Delaleu, P. Mydel, Impact of fibrinogen carbamylation on fibrin clot formation and stability, Thromb. Haemost. 2017 May 8; 117(5): 899-910.10.1160/TH16-09-0704544260728382370
Open DOI Search in Google Scholar Back to article
38. Vogels SC, Emmelot-Vonk MH, Verhaar HJ, Koek HL. The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review. Maturitas. 2012;71(4):331-6.10.1016/j.maturitas.2012.01.00822318093
Open DOI Search in Google Scholar Back to article
39. Moodalbail DG, Reiser KA, Detre JA, Schultz RT, Herrington JD, Davatzikos C, et al. Systematic review of structural and functional neuroimaging findings in children and adults with CKD. Clin J Am Soc Nephrol CJASN. 2013; 8(8):1429-48.10.2215/CJN.11601112373191523723341
Open DOI Search in Google Scholar Back to article
40. Wetmore JB, Phadnis MA, Ellerbeck EF, Shireman TI, Rigler SK, Mahnken JD. Relationship between stroke and mortality in dialysis patients. Clin J Am Soc Nephrol. 2015; 10(1):80-9. 64.10.2215/CJN.02900314428440625318759
Open DOI Search in Google Scholar Back to article
41. Dad T, Weiner DE. Stroke and chronic kidney disease: Epidemiology, pathogenesis, and management across kidney disease stages. Semin Nephrol. 2015; 35: 311-322.10.1016/j.semnephrol.2015.06.003456769126355250
Open DOI Search in Google Scholar Back to article
42. Koeth, R.A.; Kalantar-Zadeh, K.; Wang, Z.; Fu, X.; Tang, W.H.; Hazen, S.L. Protein carbamylation predicts mortality in ESRD. J. Am. Soc. Nephrol. JASN. 2013 Apr 30; 24(5): 853-861.10.1681/ASN.2012030254363678723431074
Open DOI Search in Google Scholar Back to article
43. D’Apolito, M.; Du, X.; Zong, H.; Catucci, A.; Maiuri, L.; Trivisano, T.; Pettoello-Mantovani, M.; Campanozzi, A.; Raia, V.; Pessin, J.E.; et al. Urea-induced ros generation causes insulin resistance in mice with chronic renal failure. J. Clin. Investig. 2010 Jan;120(1):203-1310.1172/JCI37672279867419955654
Open DOI Search in Google Scholar Back to article
44. Koppe, L.; Nyam, E.; Vivot, K.; Manning Fox, J.E.; Dai, X.Q.; Nguyen, B.N.; Trudel, D.; Attane, C.; Moulle, V.S.; MacDonald, P.E.; et al. Urea impairs beta cell glycolysis and insulin secretion in chronic kidney disease. J. Clin. Investig. 2016; 126(9): 3598-3612.
Search in Google Scholar Back to article
45. L. Gross, G. Piecha, A. Bierhaus, W. Hanke, T. Henle, P. Schirmacher, E. Ritz, Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney, Am. J. Physiol. Renal Physiol. 301: 2011;F476-485.10.1152/ajprenal.00342.201021367923
Open DOI Search in Google Scholar Back to article
46. L.M. Kraus, L. Gaber, C.R. Handorf, H.P. Marti, A.P. Kraus Jr., Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage, Swiss Med. Wkly. 2001 Mar 24;131(11-12):139-4.10.4414/smw.2001.09691
Open DOI Search in Google Scholar Back to article
47. M. Shaykh, A.A. Pegoraro, W. Mo, J.A. Arruda, G. Dunea, A.K. Singh, Carbamylated proteins activate glomerular mesangial cells and stimulate collagen deposition, J. Lab. Clin. Med. 1999;;133(3):302-8.10.1016/S0022-2143(99)90086-0
Open DOI Search in Google Scholar Back to article
48. Watanabe K, Watanabe T, Nakayama M. Cerebro-renal interactions: impact of uremic toxins on cognitive function. Neurotoxicology. 2014;44:184-93.10.1016/j.neuro.2014.06.01425003961
Open DOI Search in Google Scholar Back to article
49. Gaxatte C, Daroux M, Bloch J, Puisieux F, Deramecourt V, Boulanger E. Cognitive impairment and chronic kidney disease: which links? Nephrol Ther. 2011;7(1):10-7.10.1016/j.nephro.2010.09.00121050832
Open DOI Search in Google Scholar Back to article
50. Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int. 2011;79(1):14-22.10.1038/ki.2010.336310719220861818
Open DOI Search in Google Scholar Back to article
51. Etgen T. Kidney disease as a determinant of cognitive decline and dementia. Alzheimer’s Res Ther. 2015;7(1):29.10.1186/s13195-015-0115-4436094325780391
Open DOI Search in Google Scholar Back to article
52. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis. 2008;15(2):123-32.10.1053/j.ackd.2008.01.010250469118334236
Open DOI Search in Google Scholar Back to article
53. Bugnicourt J-M, Godefroy O, Chillon J-M, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol. 2013;24(3):353-63.10.1681/ASN.201205053623291474
Open DOI Search in Google Scholar Back to article
54. Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT et al. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β. Alzheimers Dement. 2017; 13:1004-101210.1016/j.jalz.2017.01.018557365128253478
Open DOI Search in Google Scholar Back to article
55. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18(7):1272-80.10.1093/ndt/gfg07412808161
Open DOI Search in Google Scholar Back to article
56. Kim G.H., Kim J.E., Rhie S.J., Yoon S. The Role of Oxidative Stress in Neurodegenerative Diseases.Exp Neurobiol. 2015 Dec; 24(4): 325-340.10.5607/en.2015.24.4.325468833226713080
Open DOI Search in Google Scholar Back to article
57. Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs. 2009;32(12):872-82.10.1177/03913988090320120620037892
Open DOI Search in Google Scholar Back to article
58. Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegener. 2009;4:47.10.1186/1750-1326-4-47278476019917131
Open DOI Search in Google Scholar Back to article
59. Hsieh H.L., Yang C.M. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Bio-Med Res. Int. 2013;2013:18.
Search in Google Scholar Back to article
60. Davies. M.J. Protein oxidation and peroxidationBiochemJ. 2016 Apr 1; 473(Pt 7): 805-825.10.1042/BJ20151227481957027026395
Open DOI Search in Google Scholar Back to article
61. S. Sirpal, Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease, Clin. Sci. (Lond.) 116, 2009: 681-695.10.1042/CS2008032219323651
Open DOI Search in Google Scholar Back to article
62. Yu G., Liang Y., Zheng S., Zhang H. Inhibition of myeloperoxidase by n-acetyl lysyltyrosylcysteine amide reduces oxidative stress-mediated inflammation, neuronal damage, and neural stem cell injury in a murine model of stroke. J. Pharmacol. Exp. Ther. 2018;364:311-322.
Search in Google Scholar Back to article
63. Allen C.L., Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke. 2009;4:461-470.
Search in Google Scholar Back to article
64. Vaziri, N.D.; Yuan, J.; Norris, K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am. J. Nephrol. 2013;37(1):1-6.
Search in Google Scholar Back to article
65. Jing W, Jabbari B, Vaziri ND. Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier Am J Transl Res. 2018; 10(7): 2137-2147.
Search in Google Scholar Back to article
66. Davis S. M, Pennypacker K. R.. Targeting Antioxidant Enzyme Expression as a Therapeutic Strategy for Ischemic Stroke.Neurochem Int. 2017; 107: 23-32.10.1016/j.neuint.2016.12.007546118928043837
Open DOI Search in Google Scholar Back to article
67. Eknoyan, G.; Beck, G.J.; Cheung, A.K.; Daugirdas, J.T.; Greene, T.; Kusek, J.W.; Allon, M.; Bailey, J.; Delmez, J.A.; Depner, T.A.; et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19;347(25):2010-9.10.1056/NEJMoa02158312490682
Open DOI Search in Google Scholar Back to article
68. Handley RR, Reid SJ, Brauning R, Maclean P, Mears ER, Fourie I, Patassini S, Cooper GJS, Rudiger SR, McLaughlan CJ, Verma PJ, Gusella JF, MacDonald ME, Waldvogel HJ, Bawden CS, Faull RLM, Snell RG. Brain urea increase is an early Huntington’s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases. Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11293-E11302.10.1073/pnas.1711243115574818029229845
Open DOI Search in Google Scholar Back to article
69. Meijers, B.; Vanholder, R. Hemo revisited: Why kt/vurea only tells part of the story. J. Am. Soc. Nephrol. JASN. 2016 Nov;27(11):3235-3237.10.1681/ASN.2016040417508490027270443
Open DOI Search in Google Scholar Back to article
70. Meyer, T.W.; Sirich, T.L.; Fong, K.D.; Plummer, N.S.; Shafi, T.; Hwang, S.; Banerjee, T.; Zhu, Y.; Powe, N.R.; Hai, X.; et al. Kt/vurea and nonurea small solute levels in the hemodialysis study. J. Am. Soc. Nephrol. JASN. 2016 Nov; 27 (11) 3469-3478.10.1681/ASN.2015091035508489027026365
Open DOI Search in Google Scholar Back to article
71. M. T. Velasquez, A. Ramezani and D. S. Raj. Urea and protein carbamylation in ESRD: surrogate markers or partners in crime? Kidney International, 2015; Jun;87(6):1092-4.10.1038/ki.2015.78490307826024026
Open DOI Search in Google Scholar Back to article
72. Vanholder, R.; Glorieux, G.; Eloot, S. Once upon a time in dialysis: The last days of kt/v? 88, 460-465. Kidney Int. 2015 Sep;88(3):460-5.10.1038/ki.2015.155
Open DOI Search in Google Scholar Back to article
73. A.H. Berg, C. Drechsler, J. Wenger, R. Buccafusca, T. Hod, S. Kalim, W. Ramma, S.M. Parikh, H. Steen, D.J. Friedman, J. Danziger, C. Wanner, R. Thadhani, S.A. Karumanchi, Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure, Sci. Transl. Med. 2013 Mar 6;5(175):175ra29.10.1126/scitranslmed.3005218
Open DOI Search in Google Scholar Back to article
74. S. Jaisson, L. Gorisse, C. Pietrement, P. Gillery, Quantification of plasma homocitrulline using hydrophilic interaction liquid chromatography (HILIC) coupled to tandem mass spectrometry, Anal. Bioanal. Chem. 2012; 1635-1641.10.1007/s00216-011-5619-6
Open DOI Search in Google Scholar Back to article
75. S. Delanghe, A. Moerman, A. Pletinck, E. Schepers, G. Glorieux, W. Van Biesen, J.R. Delanghe, M.M. Speeckaert, Quantification of carbamylated albumin in serum based on capillary electrophoresis, Electrophoresis. 2017; 2135-2140.10.1002/elps.201700068
Open DOI Search in Google Scholar Back to article
76. Desmons, S. Jaisson, C. Pietrement, P. Rieu, A. Wynckel, P. Gillery, Homocitrulline: a new marker for differentiating acute from chronic renal failure, Clin. Chem. Lab. Med. 2016 Jan;54(1):73-9.10.1515/cclm-2015-0398
Open DOI Search in Google Scholar Back to article
77. Kwan, J. T., Carr, E. C., Bending, M. R., and Barron, J. L. Determination of carbamylated hemoglobin by highperformance liquid chromatography. Clinical Chemistry, 1990; 36(4):607-610.10.1093/clinchem/36.4.607
Open DOI Search in Google Scholar Back to article
78. Stim, J., Shaykh, M., Anwar, F., Ansari, A., Arruda, J. A., and Dunea, GFactors determining hemoglobin carbamylation in renal failure. Kidney Int. 1995;48(5) :1605-1610.10.1038/ki.1995.454
Open DOI Search in Google Scholar Back to article
79. Tarif, N., Shaykh, M., Stim, J., Arruda, J. A., and Dunea, G. Carbamylated hemoglobin in hemodialysis patients. Am J Kidney Dis 1997 Sep;30(3):361-5.10.1016/S0272-6386(97)90280-8
Open DOI Search in Google Scholar Back to article
80. Laaksonen S, Metsärinne K, Voipio-Pulkki LM, et al. Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve 2002;25:884-90.10.1002/mus.1015912115978
Open DOI Search in Google Scholar Back to article
81. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Kiernan MC. Sensory nerve excitability and neuropathy in end stage kidney disease. J Neurol Neurosurg Psychiatry. 2006;77:548-51.10.1136/jnnp.2005.079988207749516543542
Open DOI Search in Google Scholar Back to article
82. American Academy of Neurology guideline summary for clinicians: detection, diagnosis and management of dementia. 2013. http://tools.aan.com/professionals/practice/pdfs/dementia_guideline.
Search in Google Scholar Back to article
83. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. American Journal of Kidney Diseases 2002; 39(2):S14-S266.2002;
Search in Google Scholar Back to article
84. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD American Journal of Kidney Diseases. 2014; 63( 5) : 713-735.10.1053/j.ajkd.2014.01.416
Open DOI Search in Google Scholar Back to article
85. Juncos L.A., Chandrashekar K., Juncos L.I. Cognitive Impairment/Dementia in Chronic Renal Disease. In: Gargiulo P., Mesones-Arroyo H. (eds) Psychiatry and Neuroscience Update. 2017; Vol. II. Springer, Cham10.1007/978-3-319-53126-7_36
Open DOI Search in Google Scholar Back to article
86. Hays R, Kallich J, Mapes D, et al. Kidney Disease Quality of Life Short Form (KDQOL-SF™), Version 1.3: A Manual for Use and Scoring. Santa Monica, CA: RANDP-, 19947994.
Search in Google Scholar Back to article
87. Petersen RC. Mild cognitive impairment. N Engl J Med. 2011;364(23):2227-3410.1056/NEJMcp0910237
Open DOI Search in Google Scholar Back to article
88. Vicenzini E., Ricciardi M.C., Altieri M., Puccinelli F., Bonaffini N., Di Piero V., Lenzi G.L. Cerebrovascular reactivity in degenerative and vascular dementia: A transcranial doppler study. Eur. Neurol. 2007;58:84-89
Search in Google Scholar Back to article
89. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.10.1016/0022-3956(75)90026-6
Open DOI Search in Google Scholar Back to article
90. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology 1999;53:1660.10.1212/WNL.53.8.1660
Open DOI Search in Google Scholar Back to article
91. Shende VS, Sharma RD, Pawar SM, Waghmare SN. A study of median nerve entrapment neuropathy at wrist in uremic patients. Indian J Nephrol. 2015. 25:229-33.10.4103/0971-4065.144425449547726199474
Open DOI Search in Google Scholar Back to article
92. Issar T, Arnold R, Kwai NCG, et al. The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study. Clin Neurophysiol. 2018;129:889-94.10.1016/j.clinph.2018.02.12029547762
Open DOI Search in Google Scholar Back to article
93. England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64:199-207.10.1212/01.WNL.0000149522.32823.EA15668414
Open DOI Search in Google Scholar Back to article
94. Smyth B, et al. Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol BMJ Open. 2019 Jan 15;9(1):e023736.10.1136/bmjopen-2018-023736634042430782714
Open DOI Search in Google Scholar Back to article
95. Doulgerakis D, Moyssakis I, Kapelios CJ, Eleftheriadou I, Chorepsima S, Michail S, Tentolouris N. Cardiac autonomic neuropathy predicts all-cause and cardiovascular mortality in patients with end-stage renal failure: a 5- year prospective study. Kidney Int Rep. 2017; 02:686-69410.1016/j.ekir.2017.03.002567862829142986
Open DOI Search in Google Scholar Back to article
96. Badarau S, Siriopol D, Drugus D, et al. Electrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients. Int Urol Nephrol. 2015;47:1703-1708.10.1007/s11255-015-1063-426329736
Open DOI Search in Google Scholar Back to article
97. Vaziri, N.D. Effect of synbiotic therapy on gut-derived uremic toxins and the intestinal microbiome in patients with ckd. Clin. J. Am. Soc. Nephrol. CJASN 2016, 11, 199-201.10.2215/CJN.13631215474105226772192
Open DOI Search in Google Scholar Back to article
98. Ranganathan N. Reality of “Enteric Dialysis ®” with Probiotics and Prebiotics to Delay the Need of Conventional Dialysis. J Nephrol Ther. 2018, 8: 319.10.4172/2161-0959.1000319
Open DOI Search in Google Scholar Back to article
99. Yamaguchi J, Tanaka T, Inagi R. Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy? Nephron. 2017;135(3):201-206.10.1159/00045367327960172
Open DOI Search in Google Scholar Back to article
100. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18(7):1272-80.10.1093/ndt/gfg07412808161
Open DOI Search in Google Scholar Back to article
101. J.J. Carrero, P. Stenvinkel, L. Cuppari, T.A. Ikizler, K. Kalantar-Zadeh, G. Kaysen, W.E. Mitch, S.R. Price, C. Wanner, A.Y. Wang, P. ter Wee, H.A. Franch, Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM), J. Ren. Nutr. 2013 Mar;23(2):77-90.10.1053/j.jrn.2013.01.00123428357
Open DOI Search in Google Scholar Back to article
102. S. Kalim, G. Ortiz, C.A. Trottier, J.J. Deferio, S.A. Karumanchi, R.I. Thadhani, A.H. Berg, The effects of parenteral amino acid therapy on protein carbamylation in maintenance hemodialysis patients, J. Ren. Nutr. 2015 Jul;25(4):388-92.10.1053/j.jrn.2015.01.019446957025753604
Open DOI Search in Google Scholar Back to article
103. Stosovic M, Nikolic A, Stanojevic M, et al. Nerve conduction studies and prediction of mortality in hemodialysis patients. Ren Fail 2008;30:695-9.10.1080/0886022080221289018704818
Open DOI Search in Google Scholar Back to article
104. Jurcić D, Bilić A, Schwarz D, et al. Clinical course of uremic neuropathy in long-term hemodialysis. Coll Antropol 2008;32:771-5.
Search in Google Scholar Back to article
105. Ho DT, Rodig NM, Kim HB, Lidov HGW, Shapiro FD, Raju GP, Kang PB. Rapid reversal of uremic neuropathy following renal transplantation in an adolescent. Pediatr Transplant 2012; 16: E296-E300.10.1111/j.1399-3046.2011.01630.x331173322188489
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/sjecr-2021-0013 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)

Journal RSS Feed

Language: English

Submitted on: Feb 22, 2021

Accepted on: Mar 6, 2021

Published on: Sep 27, 2021

Published by: University of Kragujevac, Faculty of Medical Sciences

In partnership with: Paradigm Publishing Services

Keywords:

chronic renal failure,

neuropathy,

carbamylation,

pathological involution

Related subjects:

Medicine,

Clinical medicine,

Clinical medicine, other

© 2021 Tatjana Lazarevic, Zoran Kovacevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT